ADA Scientific Sessions 2025 Abstract·13 JunStudy on the Efficacy and Safety of Henagliflozin Combined with Continuous Subcutaneous Insulin Infusion in the Treatment of Type 2 Diabetes—A Multicenter, Randomized, Open-Label, Controlled StudyTrial in peopleInterventionsPaper